CDC: Transplant, CKD Patients at High Risk for Severe COVID-19 Illness
Many patients with kidney disease are at high risk for severe COVID-19 illness, according to a CDC update.
Many patients with kidney disease are at high risk for severe COVID-19 illness, according to a CDC update.
In a study of kidney transplant recipients, PPI users had an almost 2-fold increased risk of mortality compared with nonusers.
A study of 1029 living kidney donors in Norway found that they had significant 64% increased odds of ischemic heart disease compared with health controls.
In 2 small case series of solid-organ transplant recipients, the potassium binders patiromer and sodium zirconium cyclosilicate appeared effective in the short term in managing hyperkalemia.
In a study, cardiovascular structure and function at 5 years did not differ significantly among living kidney donors and healthy controls.
In a study of white related living kidney donors and recipients, investigators found that older donors are at increased risk of end-stage renal disease (ESRD) if the recipients are older at the time of ESRD onset.
In a study, recipients of A2 incompatible kidneys from living donors had a 60% higher risk for death-censored graft failure than recipients of blood type compatible kidneys.
Most programs put live-donor transplants on hold.
Kidney transplant recipients with pre-existing pulmonary hypertension had a 1.5-fold increased risk for death compared with recipients without the condition, a study found.
Compared with kidney transplant candidates who refuse a kidney from a donor with acute kidney injury, those who accept such a kidney had a 48% decreased risk of death, a study found.